Following the reforms introduced under CanG, prescribing pathways, patient access and the regulatory environment are continuing to develop. The Frankfurt Symposium will bring together clinicians, researchers, policymakers, patient advocates and responsible industry professionals to explore what those changes mean for medical cannabis in practice.

The programme will focus on the latest clinical evidence for cannabis-based medicines, the impact of CanG and Germany’s changing regulatory framework, prescribing guidance and clinical best practice, patient experiences, emerging cannabinoid research and practical insight from clinicians working in Germany and across Europe.

Sessions will combine expert presentations, panel discussions and audience Q&A, creating an opportunity to examine both the progress being made and the challenges that remain as Germany’s medical cannabis sector develops.

The event is relevant to doctors and specialist clinicians, GPs, pharmacists, nurses and allied healthcare professionals, researchers, academics, policymakers, regulators, patient organisations and responsible businesses working within medical cannabis.

For anyone seeking a clearer understanding of Germany’s changing clinical and regulatory landscape, Frankfurt offers an opportunity to hear from those working directly within it and to connect with professionals from across Germany and Europe.

Members, supporters and followers can receive 10% off tickets using the discount code:

CTA10

Book Frankfurt Tickets